INFLAMMATORY S1706
Study #S1706A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently with Radiotherapy versus Radiotherapy alone for Inflammatory Breast Cancer
Back To Clinical Trials NCI Database Entry
A Phase II Randomized Trial of Olaparib (NSC-747856) Administered Concurrently with Radiotherapy versus Radiotherapy alone for Inflammatory Breast Cancer
Back To Clinical Trials NCI Database Entry